78
Views
6
CrossRef citations to date
0
Altmetric
Clinical Features

The Implications of Tamper–Resistant Formulations for Opioid Rotation

, MD & , PhD
Pages 101-109 | Published online: 13 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Joseph V Pergolizzi$suffix/text()$suffix/text(), Robert Taylor$suffix/text()$suffix/text(), Jo Ann LeQuang & Robert B Raffa. (2018) Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product. Journal of Pain Research 11, pages 301-311.
Read now
Mellar P. Davis. (2016) Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 823-831.
Read now

Articles from other publishers (4)

Parmita Phaugat, Suchitra Nishal & Rakhi Dhiman. (2022) Abuse-Deterrent Formulations in Constraining the Abuse Potential of Prescription Medicines: A Myth or Truth. Current Drug Delivery 19:4, pages 466-478.
Crossref
Eric S. Hsu. (2017) Medication Overuse in Chronic Pain. Current Pain and Headache Reports 21:1.
Crossref
Mona Darwish, Mary Bond, William Tracewell, Philmore RobertsonJrJr & Ronghua Yang. (2014) Pharmacokinetics of Hydrocodone Extended-Release Tablets Formulated with Different Levels of Coating to Achieve Abuse Deterrence Compared with a Hydrocodone Immediate-Release/Acetaminophen Tablet in Healthy Subjects. Clinical Drug Investigation 35:1, pages 13-22.
Crossref
E. J. Cone, R. Heltsley, D. L. Black, J. M. Mitchell, C. P. LoDico & R. R. Flegel. (2013) Prescription Opioids. I. Metabolism and Excretion Patterns of Oxycodone in Urine Following Controlled Single Dose Administration. Journal of Analytical Toxicology 37:5, pages 255-264.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.